Dali Zong
- Molecular Biology top 10%
- Oncology top 10%
- Cancer Research top 10%
- Genetics
- Pulmonary and Respiratory Medicine
- Co-authors
- Rolf LewensohnKristina ViktorssonAndré NussenzweigPetra HåågElsa CallénBirgitta MörkNancy WongLovisa Lundholm
- Topics
- DNA Repair Mechanisms (16 papers)CRISPR and Genetic Engineering (8 papers)PARP inhibition in cancer therapy (7 papers)
- Partner nations
- United StatesSwedenChina
In The Last Decade
Dali Zong
25 papers receiving 868 citations
Peers
Comparison fields: 5 of 80
- Molecular Biology 748
- Oncology 318
- Cancer Research 167
- Genetics 74
- Pulmonary and Respiratory Medicine 46
Countries citing papers authored by Dali Zong
This map shows the geographic impact of Dali Zong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dali Zong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dali Zong more than expected).
Fields of papers citing papers by Dali Zong
This network shows the impact of papers produced by Dali Zong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dali Zong. The network helps show where Dali Zong may publish in the future.
Co-authorship network of co-authors of Dali Zong
This figure shows the co-authorship network connecting the top 25 collaborators of Dali Zong. A scholar is included among the top collaborators of Dali Zong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dali Zong. Dali Zong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 9 | |
| 5 | 69 | |
| 6 | 2 | |
| 7 | 21 | |
| 8 | 17 | |
| 9 | 15 | |
| 10 | 16 | |
| 11 | ZNF488 is an independent prognostic indicator in nasopharyngeal carcinoma and promotes cell adhesion and proliferation via collagen IV/FAK/AKT/Cyclin D1 pathway | 1 |
| 12 | 17 | |
| 13 | 83 | |
| 14 | 85 | |
| 15 | 73 | |
| 16 | 22 | |
| 17 | 27 | |
| 18 | 36 | |
| 19 | 90 | |
| 20 | 33 |
About Dali Zong
Dali Zong is a scholar working on Oncology, Molecular Biology and Toxicology, having authored 27 papers that have together received 873 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (16 papers), CRISPR and Genetic Engineering (8 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Oncology (318 citations), Cancer Research (167 citations) and Molecular Biology (748 citations). Dali Zong has collaborated with scholars based in United States, Sweden and China. Frequent co-authors include Rolf Lewensohn, Kristina Viktorsson, André Nussenzweig, Petra Hååg, Elsa Callén, Birgitta Mörk, Nancy Wong, Lovisa Lundholm, Wei Wu and Michael J. Kruhlak. Their work appears in journals such as Science, Nucleic Acids Research and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.